Literature DB >> 30177380

RNAi/CRISPR Screens: from a Pool to a Valid Hit.

Anne Schuster1, Hélène Erasimus1, Sabrina Fritah1, Petr V Nazarov2, Eric van Dyck1, Simone P Niclou3, Anna Golebiewska4.   

Abstract

High-throughput genetic screens interfering with gene expression are invaluable tools to identify gene function and phenotype-to-genotype interactions. Implementing such screens in the laboratory is challenging, and the choice between currently available technologies based on RNAi and CRISPR/Cas9 (CRISPR-associated protein 9) is not trivial. Identifying reliable candidate hits requires a streamlined experimental setup adjusted to the specific biological question. Here, we provide a critical assessment of the various RNAi/CRISPR approaches to pooled screens and discuss their advantages and pitfalls. We specify a set of best practices for key parameters enabling a reproducible screen and provide a detailed overview of analysis methods and repositories for identifying the best candidate gene hits.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Keywords:  CRISPR/Cas9; CRISPRa; CRISPRi; RNAi; essential genes; library pooled screens

Mesh:

Year:  2018        PMID: 30177380     DOI: 10.1016/j.tibtech.2018.08.002

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  42 in total

1.  A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors.

Authors:  Laura M Rogers; Zhaoming Wang; Sarah L Mott; Adam J Dupuy; George J Weiner
Journal:  Cancer Immunol Res       Date:  2020-07-01       Impact factor: 11.151

2.  Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma.

Authors:  Atsushi Takai; Hien Dang; Naoki Oishi; Subreen Khatib; Sean P Martin; Dana A Dominguez; Ji Luo; Rachel Bagni; Xiaolin Wu; Katie Powell; Qing-Hai Ye; Hu-Liang Jia; Lun-Xiu Qin; Jinqiu Chen; Gary A Mitchell; Xiaoling Luo; Snorri S Thorgeirsson; Xin Wei Wang
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

3.  Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy.

Authors:  Danielle E Anderson; Jin Cui; Qian Ye; Baoying Huang; Ya Tan; Chao Jiang; Wenhong Zu; Jing Gong; Weiqiang Liu; So Young Kim; Biao Guo Yan; Kristmundur Sigmundsson; Xiao Fang Lim; Fei Ye; Peihua Niu; Aaron T Irving; Haoyu Zhang; Yefeng Tang; Xuming Zhou; Yu Wang; Wenjie Tan; Lin-Fa Wang; Xu Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

4.  Ubiquitin-mediated DNA damage response is synthetic lethal with G-quadruplex stabilizer CX-5461.

Authors:  Tehmina Masud; Charles Soong; Hong Xu; Justina Biele; Saelin Bjornson; Steven McKinney; Samuel Aparicio
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 5.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

Review 6.  Discovering antiviral restriction factors and pathways using genetic screens.

Authors:  Chloe E Jones; Wenfang S Tan; Finn Grey; David J Hughes
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 3.891

7.  XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase.

Authors:  Abhishek Bharadwaj Sharma; Hélène Erasimus; Lia Pinto; Marie-Christine Caron; Diyavarshini Gopaul; Thibaut Peterlini; Katrin Neumann; Petr V Nazarov; Sabrina Fritah; Barbara Klink; Christel C Herold-Mende; Simone P Niclou; Philippe Pasero; Patrick Calsou; Jean-Yves Masson; Sébastien Britton; Eric Van Dyck
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

Review 8.  Research Techniques Made Simple: CRISPR Genetic Screens.

Authors:  Auke B C Otten; Bryan K Sun
Journal:  J Invest Dermatol       Date:  2020-04       Impact factor: 8.551

Review 9.  Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer.

Authors:  Samantha M Fix; Amir A Jazaeri; Patrick Hwu
Journal:  Cancer Discov       Date:  2021-02-09       Impact factor: 39.397

Review 10.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.